Restart Life Sciences Provides Performance and Revenue Trend Update on Newly Acquired Superseed Cereals and Oatmeal Brand Portfolio

Operational Update on Acquired Assets

• Restart Life Sciences provided a March 2026 performance update for its wholly owned subsidiary, Holy Crap Foods Inc., acquired in February 2026.
• Total Brand Sales for March 2026 were $126,348, down from $147,139 in March 2025 (YoY decline of ~14%).
• Direct Wholesale Revenue increased to $57,281 compared to $45,727 in the prior year period.
• Amazon Canada sales reached a record high for the last 36 months at $11,058.
• Ecommerce revenue dipped slightly to $24,464 from $26,732 in March 2025.
• Management attributes the total sales decline to a "deliberate shift in total wholesale channel mix" and strategic realignment rather than organic weakness.

Revenue Contraction Risk

• The 14% year-over-year decline in total brand sales contradicts the initial acquisition narrative of immediate growth accretion.
• While direct wholesale grew, the overall revenue contraction suggests integration challenges or market headwinds not fully offset by channel shifts.
• This news does not fundamentally alter the company's valuation thesis but confirms operational friction post-acquisition.

Business Model

• Restart Life Sciences operates in the functional wellness and health food sector.
• Flagship Project: Holy Crap Foods Inc., acquired for $1M cash in February 2026.
• Product Portfolio: Cereals, oatmeal brands targeting brain health, gut-brain axis support, and vitality (BrainQ™, BrainBalls™).